Freddy E. Escorcia, Ph.D. - Publications

2010 Weill Cornell Medical College, New York, NY, United States 
Pharmacology, Oncology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pereira PMR, Norfleet J, Lewis JS, Escorcia FE. ImmunoPET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32646879 DOI: 10.2967/Jnumed.120.244897  0.377
2020 Pereira PMR, Edwards KJ, Mandleywala K, Carter LM, Escorcia FE, Campesato LF, Cornejo M, Abma L, Mohsen AA, Iacobuzio-Donahue CA, Merghoub T, Lewis JS. iNOS regulates the therapeutic response of pancreatic cancer cells to radiation therapy. Cancer Research. PMID 32086240 DOI: 10.1158/0008-5472.Can-19-2991  0.393
2020 Escorcia FE, Houghton JL, Abdel-Atti D, Pereira PR, Cho A, Gutsche NT, Baidoo KE, Lewis JS. ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors. Theranostics. 10: 151-165. PMID 31903112 DOI: 10.7150/Thno.37098  0.395
2019 Escorcia F, Houghton J, Abdel-Atti D, Pereira P, Cho A, Lewis J. Met-Targeted Radioligand Therapy in KRAS-pathway Activated Pancreatic Cancer Resistant to Met Kinase Inhibitors International Journal of Radiation Oncology*Biology*Physics. 105: E235. DOI: 10.1016/J.Ijrobp.2019.06.2007  0.314
2018 Escorcia FE, Steckler JM, Abdel-Atti D, Price EW, Carlin SD, Scholz WW, Lewis JS, Houghton JL. Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29508263 DOI: 10.1007/S11307-018-1177-Z  0.343
2016 Röhrig F, Vorlová S, Hoffmann H, Wartenberg M, Escorcia FE, Keller S, Tenspolde M, Weigand I, Gätzner S, Manova K, Penack O, Scheinberg DA, Rosenwald A, Ergün S, Granot Z, et al. VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. Oncogene. PMID 27270432 DOI: 10.1038/Onc.2016.182  0.586
2016 Taunk NK, Moraes FY, Escorcia FE, Mendez LC, Beal K, Marta GN. External beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastoma. Expert Review of Anticancer Therapy. 16: 347-58. PMID 26781426 DOI: 10.1586/14737140.2016.1143364  0.312
2014 Villa JC, Chiu D, Brandes AH, Escorcia FE, Villa CH, Maguire WF, Hu CJ, de Stanchina E, Simon MC, Sisodia SS, Scheinberg DA, Li YM. Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancer. Cell Reports. 8: 1077-92. PMID 25131208 DOI: 10.1016/J.Celrep.2014.07.028  0.644
2014 Henke E, Roehrig F, Hoffmann H, Escorcia F, Wartenberg M, Volova S, Gaetzner S, Rosenwald A, Erguen S, Scheinberg D, Granot Z. 266 Auxiliar treatment by targeting the extracellular matrix to improve drug delivery and therapeutic response European Journal of Cancer. 50: 89. DOI: 10.1016/S0959-8049(14)70392-2  0.506
2013 Mulvey JJ, Villa CH, McDevitt MR, Escorcia FE, Casey E, Scheinberg DA. Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery Nature Nanotechnology. 8: 763-771. PMID 24077028 DOI: 10.1038/Nnano.2013.190  0.714
2011 Scheinberg DA, Villa CH, Escorcia F, Mcdevitt MR. Carbon Nanotubes Drug Delivery in Oncology: From Basic Research to Cancer Therapy. 2: 1163-1185. DOI: 10.1002/9783527634057.ch36  0.641
2010 Escorcia FE, Henke E, McDevitt MR, Villa CH, Smith-Jones P, Blasberg RG, Benezra R, Scheinberg DA. Selective killing of tumor neovasculature paradoxically improves chemotherapy delivery to tumors. Cancer Research. 70: 9277-86. PMID 21045141 DOI: 10.1158/0008-5472.Can-10-2029  0.713
2010 Scheinberg DA, Villa CH, Escorcia FE, McDevitt MR. Conscripts of the infinite armada: systemic cancer therapy using nanomaterials. Nature Reviews. Clinical Oncology. 7: 266-76. PMID 20351700 DOI: 10.1038/Nrclinonc.2010.38  0.698
2009 Escorcia FE, Henke E, McDevitt MR, Villa C, Smith-Jones P, Blasberg R, Benezra R, Scheinberg DA. Vascular Endothelial-Cadherin Targeted Alpha-Particle Mediated Vascular Killing and Remodeling Augments Subsequent Chemotherapeutic Efficacy. Blood. 114: 3054-3054. DOI: 10.1182/Blood.V114.22.3054.3054  0.708
2009 Mallikaratchy P, Ruggiero A, Maguire W, Piersanti K, Gardner J, Villa C, Escorcia F, Palomba ML, Heaney M, McDevitt MR, Scheinberg DA. Multivalent DNA Aptamer-Based Therapeutic Agents for Lymphoma and Leukemia. Blood. 114: 2711-2711. DOI: 10.1182/Blood.V114.22.2711.2711  0.69
2008 Villa CH, McDevitt MR, Escorcia FE, Rey DA, Bergkvist M, Batt CA, Scheinberg DA. Synthesis and biodistribution of oligonucleotide-functionalized, tumor-targetable carbon nanotubes. Nano Letters. 8: 4221-8. PMID 19367842 DOI: 10.1021/Nl801878D  0.703
2007 Escorcia FE, McDevitt MR, Villa CH, Scheinberg DA. Targeted nanomaterials for radiotherapy. Nanomedicine (London, England). 2: 805-15. PMID 18095847 DOI: 10.2217/17435889.2.6.805  0.722
Show low-probability matches.